Rein Therapeutics, Inc.(RNTX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Rein Therapeutics, Inc. (RNTX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. RNTX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of RNTX by reported 13-F value include Voss Capital, Cable Car Capital, ADAR1 Capital Management, based on the most recent SEC filings. RNTX trades on the Nasdaq exchange and files with the SEC under CIK 1420565. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RNTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Rein Therapeutics, Inc. directly from SEC EDGAR.